BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17192765)

  • 1. Coenzyme Q10: a review of its promise as a neuroprotectant.
    Young AJ; Johnson S; Steffens DC; Doraiswamy PM
    CNS Spectr; 2007 Jan; 12(1):62-8. PubMed ID: 17192765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.
    Beal MF
    Biofactors; 1999; 9(2-4):261-6. PubMed ID: 10416039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 in neurodegenerative diseases.
    Shults CW
    Curr Med Chem; 2003 Oct; 10(19):1917-21. PubMed ID: 12871093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang L; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q treatment of neurodegenerative diseases of aging.
    Galpern WR; Cudkowicz ME
    Mitochondrion; 2007 Jun; 7 Suppl():S146-53. PubMed ID: 17485247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 as a possible treatment for neurodegenerative diseases.
    Beal MF
    Free Radic Res; 2002 Apr; 36(4):455-60. PubMed ID: 12069110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
    Smith KM; Matson S; Matson WR; Cormier K; Del Signore SJ; Hagerty SW; Stack EC; Ryu H; Ferrante RJ
    Biochim Biophys Acta; 2006 Jun; 1762(6):616-26. PubMed ID: 16647250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang LN; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD008150. PubMed ID: 22592726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.
    Beal MF; Matthews RT
    Mol Aspects Med; 1997; 18 Suppl():S169-79. PubMed ID: 9266519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
    Storch A
    Nervenarzt; 2007 Dec; 78(12):1378-82. PubMed ID: 17508194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
    Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N
    Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 in neuromuscular and neurodegenerative disorders.
    Mancuso M; Orsucci D; Volpi L; Calsolaro V; Siciliano G
    Curr Drug Targets; 2010 Jan; 11(1):111-21. PubMed ID: 20017723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.
    Zhu ZG; Sun MX; Zhang WL; Wang WW; Jin YM; Xie CL
    Neurol Sci; 2017 Feb; 38(2):215-224. PubMed ID: 27830343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 protects against amyloid beta-induced neuronal cell death by inhibiting oxidative stress and activating the P13K pathway.
    Choi H; Park HH; Koh SH; Choi NY; Yu HJ; Park J; Lee YJ; Lee KY
    Neurotoxicology; 2012 Jan; 33(1):85-90. PubMed ID: 22186599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants, supplements, and Parkinson's disease.
    Weber CA; Ernst ME
    Ann Pharmacother; 2006 May; 40(5):935-8. PubMed ID: 16622156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
    Shults CW; Haas RH; Beal MF
    Biofactors; 1999; 9(2-4):267-72. PubMed ID: 10416040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
    Avcı B; Günaydın C; Güvenç T; Yavuz CK; Kuruca N; Bilge SS
    Neurochem Res; 2021 Mar; 46(3):513-522. PubMed ID: 33247801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Negida A; Menshawy A; El Ashal G; Elfouly Y; Hani Y; Hegazy Y; El Ghonimy S; Fouda S; Rashad Y
    CNS Neurol Disord Drug Targets; 2016; 15(1):45-53. PubMed ID: 26553164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.